Skip to main content
. 2014 Sep 7;20(33):11808–11814. doi: 10.3748/wjg.v20.i33.11808

Figure 2.

Figure 2

Combination therapy using immunomodulator and anti-tumor necrosis factor agent further extended the median time from Crohn’s disease diagnosis to surgery for patients requiring surgery in years 2005 to 2010 (cohort B). TNF: Tumor necrosis factor; IM: Immunomodulator.